维生素K2联合咪达普利在高血压合并骨质疏松患者中的应用效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the efficacy of vitamin K2 combined with Midapril in patients with hypertension complicated with osteoporosis and the influence on 25 hydroxy vitamin D [25(OH)D3],beta C-terminal cross-linked telopeptides of type Ⅰcollagen (β-CTX) and N-terminal-midfragment of osteocalcin (N-MID).Methods A total of 120 patients with hypertension and osteoporosis treated in Dalian Fourth People′s Hospital from September 2019 to January 2021 were selected as the research objects,they were divided into the control group (60 cases) and the observation group (60 cases) according to computer randomization.The control group was treated with Midapril,and the observation group was treated with combined vitamin K2 based on the control group.The efficacy and satisfaction of the two groups were compared,and the levels of 25(OH)D3 and β-CTX,N-MID and receptor activator of nuclear factor-κB ligand (RANKL) before and after treatment in the two groups was recorded.Results The total effective rate in the observation group after treatment was 95.00%,which was higher than 81.67% in the control group,the difference was statistically significant (P＜0.05).The 25(OH)D3 levels after treatment in the two groups were higher than those before treatment,the β-CTX levels after treatment in the two groups were lower than those before treatment,the differences were statistically significant (P＜0.05).The level of 25(OH)D3 in the observation group after treatment was higher than that in the control group,the level of β-CTX in the observation group after treatment was lower than that of the control group,the differences were statistically significant (P＜0.05).The levels of N-MID and RANKL after treatment in the two groups were higher than those before treatment,the differences were statistically significant (P＜0.05).After treatment,the levels of N-MID and RANKL in the observation group were higher than those in the control group,the differences were statistically significant (P＜0.05).The total satisfaction of the observation group was higher than that of the control group,the difference was statistically significant (P＜0.05).Conclusion Using vitamin K2 and Midapril in the treatment of hypertensive patients with osteoporosis can effectively improve the therapeutic effect,and improve the levels of 25(OH)D3,β-CTX,N-MID,and RANKL in the body.

Key words： Vitamin K2 Midapuril Hypertension Osteoporosis 25 hydroxy vitamin D Beta C-terminal cross-linked telopeptides of type Ⅰcollagen N-terminal-midfragment of osteocalcin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Yanliang

Cite this article:

ZHENG Yanliang. Application effect of vitamin K2 combined with Midapril in patients with hypertension complicated with osteoporosis[J]. 中国当代医药, 2022, 29(17): 62-65.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I17/62

[1]	李丽，韩芬.唑来膦酸联合辛伐他汀治疗2 型糖尿病合并骨质疏松患者的骨代谢状况分析[J].国际老年医学杂志，2018，39（3）：127-129.
[3]	张黎，李燕.老年骨质疏松症患者血清1，25-二羟维生素D3与骨骼肌减少症的相关性研究[J].中国全科医学，2016，19（25）：3050-3054.
[5]	秦川，艾芬，付晓幸.中老年高血压患者使用培哚普利治疗3年对骨密度及骨代谢指标的影响[J].中国骨质疏松杂志，2020，26（3）：390-393.
[6]	周奕，薛青，萧松建.培哚普利对绝经后骨质疏松症伴高血压患者骨转换影响研究[J].中国实用内科杂志，2015，35（10）：859-861.
[10]	刘倩，孟晓燕，罗春明，等.维持性血液透析患者血管钙化与维生素K2摄入关系的研究[J].中国医药导报，2017，14（6）：88-91.
[13]	董坤伦.维生素K2结合钙剂在甲状腺功能亢进症继发骨质疏松症中的临床应用[J].中国骨质疏松杂志，2018，24（2）：218-221.
[2]	Povoroznyuk V，Nishkumay O，Lazarieva K，et al.Features of bone metabolism and their influence on arterial wall stiffness in postmenopausal women with controlled uncomplicated hypertension[J].Georgian Med News，2021，（310）：87-93.
[4]	Noel SE，Mangano KM，Mattei J，et al.Dietary approaches to stop hypertension，mediterranean，and alternative healthy eating indices are associated with bone health among puerto rican adults from the boston puerto rican osteoporosis study[J].Am J Clin Nutr，2020，111（6）：1267-1277.
[7]	Chen YN，Wei P，Yu Bs J.Higher concentration of serum Cterminal cross-linking telopeptide of type Ⅰcollagen is positively related with inflammatory factors in postmenopausal women with H-type hypertension and osteoporosis[J].Orthop Surg，2019，11（6）：1135-1141.
[8]	Kouda K，Fujita Y，Ohara K，et al.Associations between trunk-to-peripheral fat ratio and cardiometabolic risk factors in elderly Japanese men：baseline data from the Fujiwara-kyo Osteoporosis Risk in Men （FORMEN） study[J].Environ Health Prev Med，2021，26（1）：35-37.
[9]	Hijazi N，Alourfi Z.Association between hypertension，antihypertensive drugs，and osteoporosis in postmenopausal syrian women：a cross-sectional study[J].Adv Med，2020，2020：7014212.
[11]	Ahn KH，Lee Y，Sohn TY，et al.Association between relative handgrip strength and osteoporosis in older women：the Korea national health and nutrition examination survey 2014-2018[J].Ann Geriatr Med Res，2020，24（4）：243-251.
[12]	Shahriarpour Z，Nasrabadi B，Shariati-Bafghi SE，et al.Adherence to the dietary approaches to stop hypertension（DASH） dietary pattern and osteoporosis risk in postmenopausal Iranian women[J].Osteoporos Int，2020，31（11）：2179-2188.
[14]	李自军.血清RANKL、tP1NP、N-MID、B-CTX 及25-羟维生素D 在骨质疏松患者中的变化及诊断价值[J].实验与检验医学，2018，36（6）：914-916.
[15]	谢俊杰，张灿，刘夏莹，等.血脂及血清维生素D 水平预测老年女性髋部骨质疏松骨折可行性分析[J].实用骨科杂志，2021，27（3）：210-214，257.